Name | Value |
---|---|
Revenues | 148.0M |
Cost of Revenue | 44.6M |
Gross Profit | 103.5M |
Operating Expense | 126.5M |
Operating I/L | -23.0M |
Other Income/Expense | 3.1M |
Interest Income | 6.4M |
Pretax | -19.9M |
Income Tax Expense | 0.2M |
Net Income/Loss | -20.1M |
iRhythm Technologies, Inc. is a digital healthcare company specializing in ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. Its flagship Zio service offers a wire-free, patch-based, and wearable biosensor combined with a cloud-based data analytic platform, enabling physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors are single-use, wire-free, wearable patch-based biosensors that record patient's heartbeats and ECG data. iRhythm generates revenue by selling its monitoring products and services to healthcare providers and patients.